Top in cardiology: Systolic BP and CV risk, benefits of fish intake

Increased time within systolic BP target range predicted the risk for major cardiovascular events among adults with hypertension, according to researchers. This was the top story in cardiology last week. 

Another top story was about an association between fish intake and major CVD and mortality in patients with prior CVD.

Read these and more top stories in cardiology below:

Time in systolic BP target range predicts major CV event risk

Among adults with hypertension and high cardiovascular (CV) risk, greater time with systolic BP within target range predicted reduced risk for major CV events independent of traditional CV risk factors, researchers reported. Read more.

Fish intake benefits patients with prior CVD, not general population

Minimal fish intake was associated with lower risk for major CVD and mortality among patients with prior CVD, but not those without CVD, according to a study published in JAMA Internal Medicine. Read more.

FDA approves rilonacept for recurrent pericarditis in adults, children

The FDA announced it approved Arcalyst (rilonacept; Kiniksa Pharmaceuticals) to treat and reduce the risk for recurrent pericarditis in adults and children 12 years and older. Read more.

AF screening with wearable monitor beneficial in older individuals with hypertension

Atrial fibrillation (AF) screening with wearable continuous electrocardiographic monitors was well tolerated, increased AF detection and sometimes prompted anticoagulant therapy among older individuals with hypertension, researchers reported. Read more.

Obesity, CVD, other factors mean 75% of US adults may be at risk for severe COVID-19

As many as three-quarters of the U.S. adult population has at least one risk factor for severe COVID-19 infection according to CDC guidelines, which could make vaccine prioritization difficult, researchers reported. Read more.